These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10651216)

  • 1. New prospects for treatment of lupus nephritis.
    Balow JE; Boumpas DT; Austin HA
    Semin Nephrol; 2000 Jan; 20(1):32-9. PubMed ID: 10651216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the treatment of proliferative lupus nephritis.
    Balow JE; Austin HA
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):107-15. PubMed ID: 10757214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches in the treatment of lupus nephritis.
    Illei GG; Czirják L
    Expert Opin Investig Drugs; 2001 Jun; 10(6):1117-30. PubMed ID: 11772239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies in lupus - focus on nephritis.
    Cordeiro AC; Isenberg DA
    Acta Reumatol Port; 2008; 33(2):157-69. PubMed ID: 18604181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of lupus nephritis: new insights from experimental models.
    Izui S
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):610-5. PubMed ID: 8583696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
    Levite M; Zinger H; Zisman E; Reisner Y; Mozes E
    Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of lupus nephritis.
    Zimmerman R; Radhakrishnan J; Valeri A; Appel G
    Annu Rev Med; 2001; 52():63-78. PubMed ID: 11160768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical approach to lupus nephritis: recent advances.
    Molino C; Fabbian F; Longhini C
    Eur J Intern Med; 2009 Sep; 20(5):447-53. PubMed ID: 19712841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer drugs for the treatment of lupus nephritis.
    Kuiper-Geertsma DG; Derksen RH
    Drugs; 2003; 63(2):167-80. PubMed ID: 12515564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus nephritis. How latest insights into its pathogenesis promote novel therapies.
    Kulkarni OP; Anders HJ
    Curr Opin Rheumatol; 2012 Sep; 24(5):457-65. PubMed ID: 22810362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus nephritis: novel immunosuppressive modalities and future directions.
    Tumlin JA
    Semin Nephrol; 1999 Jan; 19(1):67-76. PubMed ID: 9952282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.